DOCTORS Act
- Bill Number
- S. 2650
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 1
- Policy Area
- Immigration
- Status
- Introduced
- Latest Action
- 2025-08-01: Read twice and referred to the Committee on the Judiciary.
- Last Updated
- 2025-09-18T20:07:10Z
AI-Generated Summary
Purpose
The DOCTORS Act (S. 2650) aims to address shortages of medical professionals in the United States by reallocating unused waivers that allow certain J-visa holders—exchange visitors, often international medical graduates—to avoid a required two-year return to their home country after completing U.S. training. This helps retain skilled doctors to serve in U.S. healthcare, particularly in areas with limited medical access.
Key Provisions
- Reporting Requirement: Starting September 30, 2026, and annually thereafter, state agencies that received waivers under section 212(e) of the Immigration and Nationality Act (INA) must report to the Secretary of State the total number of unused waivers from the previous fiscal year.
- Reallocation Process:
- The Secretary of State calculates the total unused waivers reported by all state agencies.
- These are reallocated equally as "supplemental waivers" to eligible state agencies for use in the next fiscal year.
- The total supplemental waivers are capped at one-third of the difference between the total waivers available for a fiscal year and those actually distributed.
- Notification: On January 1, 2026, and annually thereafter, the Secretary informs eligible state agencies about the number of supplemental waivers available to them and how they will be distributed.
- Targeted Use: Ten percent of supplemental waivers each fiscal year must support positions in facilities serving patients in medically underserved communities (areas with shortages of healthcare providers, as defined under federal public health law).
- Eligibility: Only state agencies that used at least 30 waivers in the previous fiscal year qualify as "eligible" for supplemental waivers.
Significant Changes to Existing Law
- This amends section 214(l) of the INA by adding a new paragraph (4), introducing a formal system for tracking and redistributing unused waivers—previously, unused waivers were not systematically reallocated and could expire without reuse.
- It shifts from a static distribution model to a dynamic one, allowing unused slots to benefit high-performing state agencies and prioritizing underserved areas, which was not explicitly required before.
Potential Impacts
- On Government Agencies: The Department of State gains new administrative duties for reporting, calculation, and notification, potentially streamlining waiver use but increasing workload. State agencies (typically health departments) may see more waivers available if they meet usage thresholds, encouraging efficient allocation.
- On Citizens: U.S. patients, especially in rural or low-income areas, could benefit from more international doctors filling healthcare gaps, improving access to medical services and reducing wait times.
- On International Relations: Minimal direct impact, but it may enhance the U.S. appeal as a destination for international medical talent by making visa waivers more accessible, potentially strengthening ties with countries sending J-visa holders.
- Broader Effects: Could help alleviate physician shortages in the U.S. healthcare system, though the cap on reallocations limits the scale.
Main Stakeholders Affected
- J-Visa Holders: Primarily international medical graduates and trainees who can more easily obtain waivers to stay and work in the U.S. post-training.
- State Agencies: Health or immigration-related departments in states that sponsor J-visa waivers, particularly those with high prior usage.
- Healthcare Facilities and Patients: Hospitals and clinics in medically underserved communities stand to gain from the 10% targeted allocation, directly benefiting underserved populations.
- U.S. Government: The Secretary of State and related federal agencies oversee implementation.
Notable Legal, Constitutional, or Political Implications
- Legal: Builds on existing INA frameworks without altering core visa rules, ensuring compliance with immigration law; the reallocation mechanism promotes efficient use of federal resources but may require new regulations for implementation.
- Constitutional: No major issues, as it involves congressional authority over immigration (Article I, Section 8) and does not infringe on individual rights.
- Political: Bipartisan sponsorship (by Senators Ernst and Klobuchar) highlights cross-party interest in healthcare workforce solutions; it could influence future immigration debates by focusing on skilled worker retention rather than broad enforcement.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (1)
Recent Actions
- 2025-08-01: Read twice and referred to the Committee on the Judiciary.
- 2025-08-01: Introduced in Senate
Bill Versions
- Directing Our Country’s Transfer of Residency Slots — issued 2025-08-01 — PDF (4 pages)